Pradaxa Class Action Lawsuit
Pradaxa Lawsuits If you were injured by Pradaxa, you are not alone — over 2,000 Pradaxa lawsuits are pending in a federal Multi-District Litigation (MDL). Judge David R. Herndon presides over the litigation in the U.S. District Court for the...
Januvia Class Action Lawsuit
Update: Diabetes Drugs Linked to Rhabdomyolysis December 1, 2017 – Januvia and other diabetes drugs in its class have been associated with a rare, life-threatening muscular disease called rhabdomyolysis, according to the FDA Adverse Event Reporting System (FAERS). Rhabdomyolysis occurs...
Janumet Class Action Lawsuit
Update: FDA to Investigate Janumet / Rhabdomyolysis Link December 1, 2017 – The FDA is considering taking regulatory action over Janumet and other diabetres drugs in its class after finding an increased risk of rhabdomyolysis with the drugs, according to...
IVC Filter Class Action Lawsuit
Update: Bard Ordered to Pay $3.6 Million in First IVC Filter Bellwether Trial April 4, 2018 – A federal jury in Arizona on Friday ordered C.R. Bard, Inc. to pay $3.6 million to a Georgia woman who suffered serious complications...
DePuy Hip Implant Class Action Lawsuit
Update: J&J Ordered to Pay $1 Billion in DePuy Hip Bellwether Trial December 2, 2016 – A Texas jury has found Johnson & Johnson’s DePuy Orthopaedics unit liable for over $1.04 billion in a 6-plaintiff bellwether trial alleging injuries from...
Cold Therapy Class Action Lawsuit
$12.5 Million Award in Cold Therapy Lawsuit In August 2012, a jury in California awarded a woman $12.5 million for her cold therapy lawsuit, including $5 million in compensation and $7.5 million in punitive damages against Dr. David Chao and...
Byetta Class Action Lawsuit
What is Byetta? Byetta (exenatide) is a type-2 diabetes drug that comes in a pre-filled injection pen. Byetta was developed by Amylin Pharmaceuticals from the venomous saliva of the Gila monster, a large lizard found in the American Southwest. Byetta...
Actos Class Action Lawsuit
Update: FDA Confirms Actos Bladder Cancer Link December 15, 2016 – FDA has updated its review of Actos, confirming that use of the drug may increase the risk of bladder cancer. While Actos labels already contain a warning about the...